Relative Value Partners Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.46M | Buy |
27,966
+18,245
| +188% | +$2.35M | 0.45% | 58 |
|
|
2024
Q1 | $1.17M | Buy |
9,721
+24
| +0.2% | +$2.96K | 0.07% | 140 |
|
|
2023
Q4 | $1.06M | Sell |
9,697
-580
| -6% | -$60.2K | 0.06% | 146 |
|
|
2023
Q3 | $1.06M | Buy |
10,277
+2,144
| +26% | +$231K | 0.07% | 137 |
|
|
2023
Q2 | $938K | Hold |
8,133
| – | – | 0.06% | 147 |
|
|
2023
Q1 | $865K | Sell |
8,133
-724
| -8% | -$78.2K | 0.06% | 147 |
|
|
2022
Q4 | $983K | Buy |
8,857
+3,345
| +61% | +$342K | 0.07% | 146 |
|
|
2022
Q3 | $475K | Buy |
+5,512
| New | +$492K | 0.04% | 175 |
|
|
2022
Q2 | – | Sell |
-8,000
| Closed | -$662K | – | 228 |
|
|
2022
Q1 | $662K | Buy |
8,000
+3,000
| +60% | +$237K | 0.05% | 163 |
|
|
2021
Q4 | $387K | Hold |
5,000
| – | – | 0.03% | 147 |
|
|
2021
Q3 | $379K | Hold |
5,000
| – | – | 0.03% | 149 |
|
|
2021
Q2 | $392K | Sell |
5,000
-3,523
| -41% | -$262K | 0.03% | 147 |
|
|
2021
Q1 | $632K | Hold |
8,523
| – | – | 0.05% | 125 |
|
|
2020
Q4 | $671K | Buy |
8,523
+3,283
| +63% | +$251K | 0.06% | 114 |
|
|
2020
Q3 | $418K | Hold |
5,240
| – | – | 0.04% | 123 |
|
|
2020
Q2 | $390K | Hold |
5,240
| – | – | 0.04% | 130 |
|
|
2020
Q1 | $387K | Buy |
5,240
+524
| +11% | +$41.2K | 0.05% | 126 |
|
|
2019
Q4 | $412K | Hold |
4,716
| – | – | 0.04% | 122 |
|
|
2019
Q3 | $381K | Hold |
4,716
| – | – | 0.04% | 113 |
|
|
2019
Q2 | $380K | Sell |
4,716
-105
| -2% | -$8.04K | 0.04% | 116 |
|
|
2019
Q1 | $385K | Buy |
4,821
+105
| +2% | +$7.85K | 0.04% | 123 |
|
|
2018
Q4 | $346K | Hold |
4,716
| – | – | 0.04% | 120 |
|
|
2018
Q3 | $321K | Hold |
4,716
| – | – | 0.04% | 119 |
|
|
2018
Q2 | $275K | Hold |
4,716
| – | – | 0.03% | 125 |
|
|
2018
Q1 | $245K | Hold |
4,716
| – | – | 0.03% | 132 |
|
|
2017
Q4 | $253K | Hold |
4,716
| – | – | 0.03% | 111 |
|
|
2017
Q3 | $290K | Hold |
4,716
| – | – | 0.03% | 96 |
|
|
2017
Q2 | $288K | Sell |
4,716
-472
| -9% | -$28.7K | 0.03% | 99 |
|
|
2017
Q1 | $314K | Sell |
5,188
-1,624
| -24% | -$98.5K | 0.04% | 109 |
|
|
2016
Q4 | $383K | Hold |
6,812
| – | – | 0.05% | 104 |
|
|
2016
Q3 | $406K | Hold |
6,812
| – | – | 0.05% | 97 |
|
|
2016
Q2 | $374K | Sell |
6,812
-210
| -3% | -$11.2K | 0.05% | 94 |
|
|
2016
Q1 | $354K | Buy |
7,022
+210
| +3% | +$10.3K | 0.04% | 103 |
|
|
2015
Q4 | $343K | Sell |
6,812
-3,283
| -33% | -$166K | 0.04% | 104 |
|
|
2015
Q3 | $476K | Buy |
10,095
+3,283
| +48% | +$174K | 0.06% | 87 |
|
|
2015
Q2 | $370K | Buy |
+6,812
| New | +$382K | 0.04% | 88 |
|
Other funds holding MRK
Relative Value Partners Group's MRK Position: Q2 2024 in Review
Relative Value Partners Group increased its Merck (MRK) stake by 188% in Q2 2024, buying an estimated $2.35M and bringing the position to 27,966 shares worth $3.46M. The position accounts for 0.45% of the portfolio, ranked #58.
Relative Value Partners Group first reported a position in MRK in Q2 2015 and has held it in 36 quarters since. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Relative Value Partners Group held 27,966 shares of Merck worth $3.46M as of Q2 2024.
- Relative Value Partners Group bought 18,245 Merck shares in Q2 2024, an estimated $2.35M.
- Merck made up 0.45% of Relative Value Partners Group's portfolio in Q2 2024, its #58 holding.
- Relative Value Partners Group first reported a position in Merck in Q2 2015 and has held it in 36 quarters since.
- 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Relative Value Partners Group's 13F filing for Q2 2024, filed 12 Jul 2024.